TERT and thyroid cancer, nonmedullary, 2: As mentioned above, the importance of these subclonal mutations is elusive, and since no mutated tumors were diagnosed with metastases, it is uncertain if TERT promoter mutations have the same significance in miFTCs/miOTCs as in other FTC subtypes.